Yarrow Bioscience YARW
NASDAQ YARW
$29.52 +0.41 (+1.39%)
As of: Sep 10, 2026 · 10:20 AM EDT

Yarrow Bioscience (YARW) Raw Materials (2021)

Yarrow Bioscience's (YARW) quarterly Raw Materials came in at $3.3 million in Q4 2021.

Analysis

Yarrow Bioscience (YARW) Raw Materials (2021) Analysis & Trends

Yarrow Bioscience (YARW) has reported Raw Materials for 1 consecutive years, with $3.3 million the latest figure, recorded in Q4 2021.

  • For the quarter ending Q4 2021, Raw Materials changed N/A year-over-year to $3.3 million; the trailing twelve-month figure through Dec 2021 stood at $3.3 million (changed N/A YoY), and the FY2021 full-year result was $3.3 million, changed N/A from the prior year.
  • Raw Materials held at $3.3 million in Q4 2021 per YARW's latest filing.
  • Across five years, Raw Materials topped out at $3.3 million in Q4 2021 and bottomed at $3.3 million in Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.17 Bn 622.42 Bn 17.26 Bn
2 AbbVie 446.97 Bn 440.40 Bn 12.70 Bn
3 Merck 359.56 Bn 352.42 Bn 12.21 Bn
4 Novartis Ag 269.46 Bn 261.77 Bn 11.24 Bn
5 Pfizer 156.92 Bn 145.22 Bn 10.94 Bn
6 Sanofi 52.38 Bn 45.00 Bn 10.79 Bn
7 Revolution Medicines 43.58 Bn 43.58 Bn -
8 Incyte 25.22 Bn 20.68 Bn 1.57 Bn
9 United Therapeutics 21.29 Bn 18.63 Bn 683.80 Mn
10 Yarrow Bioscience 25.73 Mn 2.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 3.30 Mn